BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025

Reuters

01 Jul

BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025

July 1 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O:

VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT WITH TORII PHARMACEUTICAL TO LAUNCH GLOBAL PIVOTAL PHASE 3 CLINICAL TRIAL TO STUDY YCANTH® FOR THE TREATMENT OF COMMON WARTS
VERRICA PHARMACEUTICALS INC - TO RECEIVE $8 MILLION MILESTONE PAYMENT IN JULY 2025
VERRICA PHARMACEUTICALS INC - TO RECEIVE $10 MILLION MILESTONE PAYMENT UPON YCANTH APPROVAL IN JAPAN
VERRICA PHARMACEUTICALS INC - TORII TO FUND FIRST $40 MILLION OF GLOBAL STUDY COSTS

Source text: ID:nGNX5TnDmB

Further company coverage: VRCA.O

(((( Reuters.briefs@thomsonreuters.com ;));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2548003039"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548003039\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2548003039?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-01 19:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548003039","market":"nz","top_or_hot":-1,"title":"BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025</title></head><body><p><span>July 1 (Reuters)</span><span> - </span>Verrica Pharmaceuticals Inc <span>VRCA.O</span>:</p><ul><li><p>VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT WITH TORII PHARMACEUTICAL TO LAUNCH GLOBAL PIVOTAL PHASE 3 CLINICAL TRIAL TO STUDY YCANTH® FOR THE TREATMENT OF COMMON WARTS</p></li><li><p>VERRICA PHARMACEUTICALS INC - TO RECEIVE $8 MILLION MILESTONE PAYMENT IN JULY 2025</p></li><li><p>VERRICA PHARMACEUTICALS INC - TO RECEIVE $10 MILLION MILESTONE PAYMENT UPON YCANTH APPROVAL IN JAPAN</p></li><li><p>VERRICA PHARMACEUTICALS INC - TORII TO FUND FIRST $40 MILLION OF GLOBAL STUDY COSTS</p></li></ul><p>Source text: <span>ID:nGNX5TnDmB</span></p><p>Further company coverage: <span>VRCA.O</span></p><p> (((( Reuters.briefs@thomsonreuters.com ;));))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-01 19:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025</title></head><body><p><span>July 1 (Reuters)</span><span> - </span>Verrica Pharmaceuticals Inc <span>VRCA.O</span>:</p><ul><li><p>VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT WITH TORII PHARMACEUTICAL TO LAUNCH GLOBAL PIVOTAL PHASE 3 CLINICAL TRIAL TO STUDY YCANTH® FOR THE TREATMENT OF COMMON WARTS</p></li><li><p>VERRICA PHARMACEUTICALS INC - TO RECEIVE $8 MILLION MILESTONE PAYMENT IN JULY 2025</p></li><li><p>VERRICA PHARMACEUTICALS INC - TO RECEIVE $10 MILLION MILESTONE PAYMENT UPON YCANTH APPROVAL IN JAPAN</p></li><li><p>VERRICA PHARMACEUTICALS INC - TORII TO FUND FIRST $40 MILLION OF GLOBAL STUDY COSTS</p></li></ul><p>Source text: <span>ID:nGNX5TnDmB</span></p><p>Further company coverage: <span>VRCA.O</span></p><p> (((( Reuters.briefs@thomsonreuters.com ;));))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRCA","symbol_name":"Verrica Pharmaceuticals Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA6TVTCQ:1","article_id":"2548003039","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548003039","pubTimestamp":1751368663,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025July 1 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","BK4007":"制药"},"translate_title":"简介-Verrica Pharmaceuticals-将于2025年7月收到800万美元的里程碑付款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRCA":0.9},"content_text":"BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025July 1 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT WITH TORII PHARMACEUTICAL TO LAUNCH GLOBAL PIVOTAL PHASE 3 CLINICAL TRIAL TO STUDY YCANTH® FOR THE TREATMENT OF COMMON WARTSVERRICA PHARMACEUTICALS INC - TO RECEIVE $8 MILLION MILESTONE PAYMENT IN JULY 2025VERRICA PHARMACEUTICALS INC - TO RECEIVE $10 MILLION MILESTONE PAYMENT UPON YCANTH APPROVAL IN JAPANVERRICA PHARMACEUTICALS INC - TORII TO FUND FIRST $40 MILLION OF GLOBAL STUDY COSTSSource text: ID:nGNX5TnDmBFurther company coverage: VRCA.O (((( Reuters.briefs@thomsonreuters.com ;));))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}